LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

The National Institutes of Health, National Cancer Institute, Center for Cancer Research, Laboratory of Human Carcinogenesis requires the procurement of an Odyssey M Chemi/Fluor Imaging Bundle Standard. This new imaging system will replace an outdated and failing protein imager to support ongoing and future intramural research projects and initiatives. The versatile system provides simplified workflows for shared use across the laboratory and division, facilitating applications such as fluorescent and colorimetric Western blots, immunocytochemistry, and Enzyme-Linked Immunosorbent Assays. Additional capabilities include protein and nucleic acid arrays, high-resolution tissue section analysis, and non-isotopic Electrophoretic Mobility Shift Assays.

The Office of the Assistant Secretary for Administration issued this combined synopsis/solicitation under solicitation number 75N91026Q00014. The acquisition is classified under NAICS 334516 for Analytical Laboratory Instrument Manufacturing and PSC 6640 for Laboratory Equipment and Supplies. Performance will take place in Bethesda, Maryland, with Shayna Simpson serving as the primary point of contact.

Responses for this requirement are due by June 9, 2026. The solicitation includes five attachments: the CSS NIH NCI, a purchase description, additional terms and conditions, security prohibitions and exclusions representations and certifications, and NIH invoicing instructions. This notice was published on June 3, 2026, and is the latest update as of that date.